Cargando…

Somatic mutations predict prognosis in myelodysplastic syndrome patients with normal karyotypes

Detalles Bibliográficos
Autores principales:	Zeng, Xiangzong, Zhang, Yu, Zhao, Ke, Zhou, Lingling, Zhou, Ya, Xuan, Li, Cao, Rui, Xu, Jun, Dai, Min, Liu, Qifa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310889/ https://www.ncbi.nlm.nih.gov/pubmed/34305138 http://dx.doi.org/10.1038/s41392-021-00606-3

Ejemplares similares

Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome
por: Zeng, Xiangzong, et al.
Publicado: (2021)

When karyotype is decisive for myelodysplastic syndromes diagnosis
por: Perazzio, Aline dos Santos Borgo, et al.
Publicado: (2019)

PB2013: THE FREQUENCY, EVOLUTION AND SIGNIFICANCE OF GENE MUTATION IN MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE
por: Xu, Feng, et al.
Publicado: (2023)

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype
por: Mallo, Mar, et al.
Publicado: (2023)

Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
por: Santini, Valeria, et al.
Publicado: (2020)

Myelodysplastic syndrome with clonal karyotype evolution associated with trisomy 8 and ASXL1 mutation in well‐controlled HIV patient: Case report and literature review
por: Mendes‐de‐Almeida, Daniela Palheiro, et al.
Publicado: (2020)

Targeted Sequencing Informs the Evaluation of Normal Karyotype Cytopenic Patients for Low-Grade Myelodysplastic Syndrome
por: Duncavage, Eric J., et al.
Publicado: (2016)

Dysplastic eosinophils in myelodysplastic syndrome: association with complex karyotypes
por: Gupta, Ruchi, et al.
Publicado: (2016)

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
por: Haase, Detlef, et al.
Publicado: (2019)

Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility
por: Shahjahani, Mohammad, et al.
Publicado: (2019)

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome
por: Jung, Seung-Hyun, et al.
Publicado: (2016)

PB1916: SOMATIC MUTATIONS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME IN RUSSIAN PATIENTS
por: Kohno, A., et al.
Publicado: (2022)

Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes
por: Slovak, Marilyn L, et al.
Publicado: (2010)

Cyclopia syndrome with normal karyotype
por: Banerjee, Sayan, et al.
Publicado: (2020)

“Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)”
por: Rasmussen, Bengt, et al.
Publicado: (2022)

Genomic variations in patients with myelodysplastic syndrome and karyotypes without numerical or structural changes
por: Ribeiro, Cristiano Luiz, et al.
Publicado: (2021)

Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype
por: Virijevic, Marijana, et al.
Publicado: (2016)

Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion
por: Feurstein, Simone, et al.
Publicado: (2018)

PB1914: CYTOGENETIC FINDINGS IN 18 CHILDREN WITH MYELODYSPLASTIC SYNDROMES BY KARYOTYPIC AND FISH ANALYSIS
por: Manola, K., et al.
Publicado: (2022)

Effectiveness of non-invasive chromosomal screening for normal karyotype and chromosomal rearrangements
por: Sun, Bo-lan, et al.
Publicado: (2023)

FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand
por: Mevatee, Piyanan, et al.
Publicado: (2017)

Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts
por: Huber, Sandra, et al.
Publicado: (2022)

Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data
por: Wang, Na, et al.
Publicado: (2020)

What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort
por: Herlin, Morten Krogh, et al.
Publicado: (2021)

Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes
por: Brecqueville, M, et al.
Publicado: (2011)

Low-level somatic JAK2 V617F mutation in myelodysplastic/ myeloproliferative neoplasm with ring sideroblasts, and thrombocytosis with co-mutated SF3B1 and CALR
por: Ji, Young Sok, et al.
Publicado: (2022)

Karyotype and DNA-Methylation Responses in Myelodysplastic Syndromes following Treatment with Traditional Chinese Formula Containing Arsenic
por: Shuzhen, Sun, et al.
Publicado: (2012)

Clinico-Pathological Spectrum and Novel Karyotypic Findings in Myelodysplastic Syndrome: Experience of Tertiary Care Center in India
por: Gupta, Ruchi, et al.
Publicado: (2017)

In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathies
por: van Engelen, Nienke, et al.
Publicado: (2022)

Partial Molar Pregnancy With Normal Karyotype
por: Al Ghadeer, Hussain A, et al.
Publicado: (2022)

New Fusion Transcripts Identified in Normal Karyotype Acute Myeloid Leukemia
por: Wen, Hongxiu, et al.
Publicado: (2012)

Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q)
por: Tefferi, Ayalew, et al.
Publicado: (2017)

Myelodysplastic Syndrome in Hemodialysis Patients
por: Ayari, Hamza, et al.
Publicado: (2019)

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
por: Falconi, Giulia, et al.
Publicado: (2018)

Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes
por: Xu, Feng, et al.
Publicado: (2022)

TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia
por: Quang, Violaine Tran, et al.
Publicado: (2023)

Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes
por: Xiong, H., et al.
Publicado: (2015)

Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome: A Retrospective Cohort Study
por: Lee, Sang Jin, et al.
Publicado: (2016)

Novel Mutations in CEBPA in Korean Patients with Acute Myeloid Leukemia with a Normal Karyotype
por: Kim, Sollip, et al.
Publicado: (2012)

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
por: Kasprzak, Annika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_974ag03gd8gcf4pcck5bm236l6